Tavaborole Patent Expiration
Tavaborole is Used for treating onychomycosis (fungal infection of the toenail). It was first introduced by Anacor Pharmaceuticals Inc
Tavaborole Patents
Given below is the list of patents protecting Tavaborole, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Kerydin | US7582621 | Boron-containing small molecules | May 26, 2027 | Anacor Pharms Inc |
| Kerydin |
US7582621 (Pediatric) | Boron-containing small molecules | Nov 26, 2027 | Anacor Pharms Inc |
| Kerydin | US7767657 | Boron-containing small molecules | May 22, 2027 | Anacor Pharms Inc |
| Kerydin | US9549938 | Boron-containing small molecules | Feb 16, 2026 | Anacor Pharms Inc |
| Kerydin |
US9549938 (Pediatric) | Boron-containing small molecules | Aug 16, 2026 | Anacor Pharms Inc |
| Kerydin | US9566289 | Boron-containing small molecules | Feb 16, 2026 | Anacor Pharms Inc |
| Kerydin |
US9566289 (Pediatric) | Boron-containing small molecules | Aug 16, 2026 | Anacor Pharms Inc |
| Kerydin | US9566290 | Boron-containing small molecules | Feb 16, 2026 | Anacor Pharms Inc |
| Kerydin |
US9566290 (Pediatric) | Boron-containing small molecules | Aug 16, 2026 | Anacor Pharms Inc |
| Kerydin | US9572823 | Boron-containing small molecules | Feb 16, 2026 | Anacor Pharms Inc |
| Kerydin |
US9572823 (Pediatric) | Boron-containing small molecules | Aug 16, 2026 | Anacor Pharms Inc |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Tavaborole Generics
Several generic applications have been filed for Tavaborole. The first generic version for Tavaborole was by Encube Ethicals Private Ltd and was approved on Oct 13, 2020. And the latest generic version is by Zydus Lifesciences Ltd and was approved on Apr 10, 2023.
Given below is the list of companies who have filed for Tavaborole generic.
1. TARO
Taro Pharmaceuticals Inc has filed for 1 generic for Tavaborole. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5% | solution | Prescription | TOPICAL | AB | May 7, 2021 |
2. ENCUBE
Encube Ethicals Private Ltd has filed for 1 generic for Tavaborole. Given below are the details of the strengths of this generic introduced by Encube.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5%
(reference standard) | solution | Prescription | TOPICAL | AB | Oct 13, 2020 |
3. CIPLA
Cipla Ltd has filed for 1 generic for Tavaborole. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5% | solution | Prescription | TOPICAL | AB | Feb 9, 2021 |
4. AMNEAL
Amneal Pharmaceuticals Llc has filed for 1 generic for Tavaborole. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5% | solution | Prescription | TOPICAL | AB | Nov 25, 2020 |
5. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Tavaborole. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5% | solution | Prescription | TOPICAL | AB | Feb 3, 2021 |
6. LUPIN LTD
Lupin Ltd has filed for 1 generic for Tavaborole. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5% | solution | Prescription | TOPICAL | AB | Feb 8, 2021 |
7. PADAGIS US
Padagis Us Llc has filed for 1 generic for Tavaborole. Given below are the details of the strengths of this generic introduced by Padagis Us.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5% | solution | Prescription | TOPICAL | AB | Oct 13, 2020 |
8. ZYDUS LIFESCIENCES
Zydus Lifesciences Ltd has filed for 1 generic for Tavaborole. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5% | solution | Prescription | TOPICAL | AB | Apr 10, 2023 |
9. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Tavaborole. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5% | solution | Prescription | TOPICAL | AB | Oct 21, 2020 |